← Leaderboards
Amil M Shah
Brigham And Women'S Hospital
$21,763,052
Attributed
$31,650,820
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.7M · FY2013–25$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,650,820 · 11
By mechanism
R01$25,917,098 · 8
RF1$4,390,219 · 1
K08$735,250 · 1
K24$608,253 · 1
Top collaborators
- Bing Yu5 shared
- Sharmila Dorbala4 shared
- Raul San Jose Estepar4 shared
- Lin Yee Chen1 shared
- James S Floyd1 shared
- Thomas H Mosley1 shared
- Michelle Christina Odden1 shared
- Elizabeth Selvin1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Sharmila Dorbala$7,782,663
- Susan Cheng$21,020,819
- Lynne W. Stevenson$4,462,830
- Scott David Solomon$17,038,706
- Marcelo F Di Carli$12,559,552
Others in their field
Top investigators on “Cardiovascular System”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Judith S Hochman · New York University School Of Medicine$110,228,771
Research focus
Cardiovascular SystemHeart FailureFunctional DisorderElderlyPreventParticipantCardiacMorbidity - Disease RatePathway InteractionsAtherosclerosis Risk In CommunitiesCohortLeft Ventricular Ejection FractionAffectEfracStructureMortalityRisk FactorsPreventionPreservationImpairmentImagePhenotypeProteinsBiological Markers
Grant awards (38)
Late-life trajectories of cardiac function to define pathways of cardiac resilience$1,924,088
R01 · FY2025 · HL · contact PI
Circulating metabolites underlying cardiometabolic risk for cardiac dysfunction and heart failure in diverse populations$1,620,016
R01 · FY2025 · HL · contact PI
Glucose patterns and clinical outcomes in the Dallas Heart Study: A pathway to precision diabetes$819,091
R01 · FY2025 · DK
Proteomic profiling to identify mechanisms of susceptibility and resilience to cardiac dysfunction in Black Americans$815,229
R01 · FY2025 · HL · contact PI
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly$672,558
R01 · FY2025 · HL · contact PI
Late-life trajectories of cardiac function to define pathways of cardiac resilience$1,818,837
R01 · FY2024 · HL · contact PI
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly$672,858
R01 · FY2024 · HL · contact PI
Mentoring patient-oriented research in deep phenotyping of cardiac function for heart failure prevention$122,147
K24 · FY2024 · HL · contact PI
Cognitive Impairment and Dementia, Vascular Brain Injury, and Atrial Myopathy: Implications for Prevention of Alzheimer's Disease-Related Dementias$4,390,219
RF1 · FY2023 · NS
Late-life trajectories of cardiac function to define pathways of cardiac resilience$1,795,592
R01 · FY2023 · HL · contact PI
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life$827,451
R01 · FY2023 · HL
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly$795,260
R01 · FY2023 · HL
Proteomic signatures to identify pathways underlying the progression to heart failure$763,132
R01 · FY2023 · HL · contact PI
Mentoring patient-oriented research in deep phenotyping of cardiac function for heart failure prevention$121,595
K24 · FY2023 · HL · contact PI
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life$1,102,200
R01 · FY2022 · HL
Proteomic signatures to identifypathways underlying the progression toheart failure$831,215
R01 · FY2022 · HL · contact PI
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly$815,189
R01 · FY2022 · HL · contact PI
Mentoring patient-oriented research in deep phenotyping of cardiac function for heart failure prevention$121,873
K24 · FY2022 · HL · contact PI
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life$1,109,964
R01 · FY2021 · HL
Proteomic signatures to identifypathways underlying the progression toheart failure$835,882
R01 · FY2021 · HL · contact PI
Quantifying cardiac structure and function to define the progression to hear failure in African Americans$685,735
R01 · FY2021 · HL · contact PI
Quantifying cardiac structure and function to define the progression to hear failure in African Americans$162,306
R01 · FY2021 · HL · contact PI
Mentoring patient-oriented research in deep phenotyping of cardiac function for heart failure prevention$121,042
K24 · FY2021 · HL · contact PI
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life$1,040,412
R01 · FY2020 · HL
Proteomic signatures to identify pathways underlying the progression to heart failure$929,711
R01 · FY2020 · HL · contact PI
Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function$870,355
R01 · FY2020 · HL · contact PI
Quantifying cardiac structure and function to define the progression to hear failure in African Americans$839,070
R01 · FY2020 · HL · contact PI
Mentoring patient-oriented research in deep phenotyping of cardiac function for heart failure prevention$121,596
K24 · FY2020 · HL · contact PI
Quantifying cardiac structure and function to define the progression to hear failure in African Americans$849,940
R01 · FY2019 · HL · contact PI
Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function$801,159
R01 · FY2019 · HL · contact PI
Quantifying cardiac structure and function to define the progression to hear failure in African Americans$851,075
R01 · FY2018 · HL · contact PI
Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function$780,391
R01 · FY2018 · HL · contact PI
Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function$888,382
R01 · FY2017 · HL · contact PI
Systolic & diastolic dysfunction in heart failure and preserved ejection fraction$163,100
K08 · FY2017 · HL · contact PI
Systolic & diastolic dysfunction in heart failure and preserved ejection fraction$163,100
K08 · FY2016 · HL · contact PI
Systolic & diastolic dysfunction in heart failure and preserved ejection fraction$136,350
K08 · FY2015 · HL · contact PI
Systolic & diastolic dysfunction in heart failure and preserved ejection fraction$136,350
K08 · FY2014 · HL · contact PI
Systolic & diastolic dysfunction in heart failure and preserved ejection fraction$136,350
K08 · FY2013 · HL · contact PI